VIDEO
Last year, cancer got 10 times as many research dollars as Alzheimer’s. Many feel that investing that kind of money into curing Alzheimer’s will succeed in wiping it out. What can America do to make this happen?
VIDEO
Last year, cancer got 10 times as many research dollars as Alzheimer’s. Many feel that investing that kind of money into curing Alzheimer’s will succeed in wiping it out. What can America do to make this happen?






This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To

The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.

Ron is making the most of his early-stage Alzheimer’s. See him share how he works with his wife to make their relationship the best that it can be.

Interestingly, loving care does not require twice the time. But it does require twice the presence.

ACTIVITIES VIDEO + ARTICLE: A one-of-a-kind Alzheimer’s center inspires and stimulate memories for people living with dementia.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On